What tribe is dawa
Searching the Web
Dawa tribe origin
Could you clarify what you mean by "Dawa"? It could refer to several things:
- Dire Dawa — a city in Ethiopia, historically inhabited by Oromo (Ittu and Jarso clans) and Somali peoples (Gurgure and Issa/Dir clans).
- A person named Dawa — common in Tibetan/Sherpa culture, where "Dawa" means "moon/Monday." It is a Sherpa name from Nepal.
- Something else entirely — a place, character, or cultural reference you have in mind.
Could you provide more context so I can give you a precise answer?
Angina and acute coronary syndromes
Reading File
Finding Sources
Searching the Web
angina acute coronary syndromes classification pathophysiology management 2024
Finding Sources
Finding Sources
Searching PubMed
"acute coronary syndrome" management
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive content from the textbooks. Let me synthesize a thorough, well-organized answer.
Angina and Acute Coronary Syndromes
Overview
Coronary artery disease (CAD) presents across a spectrum of severity. At the milder end sit asymptomatic CAD and stable angina; at the severe end lie the acute coronary syndromes (ACS) — unstable angina (UA), non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI). Sudden cardiac death (SCD) from pulseless ventricular tachycardia/fibrillation is often included as the most extreme ACS manifestation.
ACS remains among the leading causes of death in industrialized countries. In the US, ~900,000 persons experience AMI each year; ~30% die within 30 days of the event, and approximately half of deaths occur before arrival at hospital — usually within 2 hours of onset.
Angina Pectoris
Angina pectoris is intermittent chest discomfort from transient, reversible myocardial ischemia insufficient to cause myocyte necrosis. It results from ischemia-induced release of adenosine, bradykinin, and other molecules that stimulate autonomic afferent nerves.
Three Variants
| Type | Features |
|---|---|
| Stable (Typical) | Predictable, reproducible; triggered by exertion or emotional stress; relieved by rest or nitroglycerin; crushing/squeezing substernal sensation, may radiate to left arm or jaw |
| Prinzmetal (Variant) | Occurs at rest, caused by coronary artery spasm (even in angiographically normal vessels); ECG shows ST elevation; responds to nitrates and calcium channel blockers |
| Unstable | New onset, at rest, or crescendo pattern (see ACS below) |
Clinical features of classic angina (vs. less likely to be angina):
| Feature | More Likely Angina | Less Likely Angina |
|---|---|---|
| Pain quality | Dull, pressure | Sharp, stabbing |
| Duration | 2–20 min | Seconds or hours |
| Location | Substernal | Lateral chest, back |
| Reproduced by | Exertion | Inspiration or palpation |
| Associated symptoms | Present | Absent |
Canadian Cardiovascular Society (CCS) Classification
- Class I — No angina with ordinary physical activity
- Class II — Minimal limitation; angina with exertion or emotional stress
- Class III — Severe limitation; angina under normal physical conditions
- Class IV — Cannot perform any activity without angina; symptoms occur at rest
Acute Coronary Syndromes (ACS)
Pathophysiology
ACS is initiated by endothelial damage and atherosclerotic plaque disruption, triggering platelet activation and thrombus formation. Key points:
- Platelet-rich thrombi are more resistant to fibrinolysis than fibrin/erythrocyte-rich thrombi
- The resulting thrombus can occlude the lumen → ischemia → hypoxia → acidosis → infarction
- In UA, acute stenosis is usual but complete occlusion occurs in only ~20% of cases; extensive collateral circulation often prevents frank infarction
- In AMI, the occlusive, fibrin-rich thrombus is fixed and persistent → myonecrosis
- Critically, the preceding plaque is often <50% stenotic angiographically — plaque rupture, platelet activation, and thrombus formation are more important than the degree of pre-existing stenosis
- Vasospasm compounds ischemia via local mediators, sympathetic activation, epinephrine, and serotonin
- Distal microembolization of thrombotic debris causes hypoperfusion even after the proximal lesion is opened; reperfusion injury, myocardial stunning, and reperfusion dysrhythmias can result
Classification of ACS
Unstable Angina (UA)
- Least severe form of ACS; no myocardial necrosis (biomarkers negative)
- Defined semantically as angina that is:
- New onset (at least CCS class II severity, within prior 2 months), OR
- Rest angina (>20 minutes, within 1 week of presentation), OR
- Progressive/crescendo angina (increasing frequency, duration, or lower threshold within 2 months, at least CCS class III)
- Also called: preinfarction angina, accelerating angina, intermediate coronary syndrome
NSTEMI
- Myocardial necrosis with elevated troponins (above 99th percentile URL) but no ST-segment elevation
- Represents subendocardial infarction
STEMI
- Myocardial necrosis with ST-segment elevation (not reversed by nitroglycerin) or new LBBB
- Represents transmural infarction; requires emergent reperfusion
Fourth Universal Definition of MI — Types of AMI
| Type | Mechanism |
|---|---|
| Type 1 | Spontaneous MI from plaque rupture/erosion with thrombus (the "true ACS event") |
| Type 2 | MI from supply-demand mismatch (spasm, embolism, severe anemia, arrhythmia, hypotension) |
| Type 3 | Sudden cardiac death before biomarker sampling; thrombus found at autopsy/angiography |
| Type 4 | PCI-related MI (>3× 99th percentile URL biomarker rise) |
| Type 5 | CABG-related MI (>5× 99th percentile URL + new Q waves, graft occlusion, or imaging evidence) |
Clinical Presentation
Classic Presentation
Crushing substernal chest discomfort with radiation to the left arm, jaw, or back; associated diaphoresis, nausea, and dyspnea.
Atypical / Anginal Equivalents
Dyspnea is the most common anginal equivalent. Others include: isolated diaphoresis, fatigue, weakness, dizziness, nausea, anxiety. "Heartburn" or "indigestion" in a patient without prior GERD should raise strong suspicion for ACS.
Groups at highest risk for atypical presentation:
- Women — <60% report typical chest pain; more likely to have dyspnea, fatigue, cold sweats, sleep disturbance
- Elderly (>85 years) — 60–70% present without chest pain
- Diabetics — Unrecognized (silent) MI occurs in ~40% vs. ~25% in non-diabetics
- Nonwhite populations — Increased disparity in recognition and treatment
One-third of ED patients ultimately diagnosed with AMI did not have chest pain on presentation.
Diagnosis
ECG
- Crucial first step; must be interpreted rapidly
- Limitations: initial non-diagnostic findings, evolving changes, anatomic blind spots, confounding patterns (LBBB)
- Recognize high-risk patterns that don't meet classic STEMI criteria: Wellens syndrome, de Winter syndrome, Sgarbossa criteria (LBBB + concordant ST changes), significant aVR elevation
Cardiac Biomarkers
- Troponin I or T are the gold-standard markers of myocardial necrosis
- Must be above the 99th percentile URL with a rise or fall pattern to indicate acute injury
- High-sensitivity troponin (hs-Tn) — increases detection sensitivity and reduces evaluation time; protocols allow earlier rule-out/rule-in
- CK-MB is also elevated in NSTEMI/STEMI but is less sensitive and specific than troponin
Risk Stratification Tools
- HEART score (History, ECG, Age, Risk factors, Troponin) — widely used in ED
- EDACS (Emergency Department Assessment of Chest Pain Score)
- Low-risk patients by validated protocols can be safely discharged with outpatient follow-up
Management
STEMI
- Emergent reperfusion is the priority
- Primary PCI is preferred: goal door-to-balloon time ≤90 minutes
- If PCI is not available: fibrinolytic therapy within 30 minutes of presentation
- Adjuncts: antiplatelet therapy (aspirin + P2Y12 inhibitor), anticoagulation, beta-blockers, ACE inhibitors, statins
NSTEMI/UA
- Risk-stratify to guide timing of invasive evaluation
- Antiplatelet (dual antiplatelet therapy), anticoagulation, nitrates, beta-blockers
- Early invasive strategy for high-risk features (elevated troponins, dynamic ECG changes, hemodynamic instability)
Stable Angina
- Sublingual nitroglycerin for acute episodes
- Beta-blockers (first-line) for prophylaxis; calcium channel blockers, long-acting nitrates
- Risk factor modification; statins; aspirin
- Revascularization (PCI or CABG) for refractory symptoms or high-risk anatomy
Key Risk Factors for ACS
Traditional: age, tobacco smoking, hypertension, diabetes mellitus, hyperlipidemia, family history of premature CAD (<50 years), obesity
Less common: antiphospholipid syndrome, rheumatoid arthritis, HIV, SLE (women with SLE aged 35–44 have markedly elevated CAD risk), cocaine/sympathomimetic use
Recent Evidence
Recent high-quality evidence relevant to ACS management includes:
- Early invasive vs. conservative strategy in older ACS patients — a 2025 meta-analysis in JAMA Internal Medicine (PMID 40549394) addressed optimal revascularization strategy in the elderly
- Clopidogrel vs. aspirin for secondary prevention — a 2025 Lancet individual patient data meta-analysis (PMID 40902613) has updated guidance on long-term antiplatelet choices
- The 2025 ACC/AHA/ACEP/NAEMSP/SCAI ACS Guideline consolidates and replaces the 2013 STEMI and 2014 NSTE-ACS guidelines, incorporating the latest trial data
Sources: Rosen's Emergency Medicine, 9th ed.; Robbins & Kumar Basic Pathology; Braunwald's Heart Disease — medical library textbooks
This is a shared conversation. Sign in to Orris to start your own chat.